Opthea
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 4 650 Chapel St, South Yarra, Victoria...Website
www.opthea.comRevenue
<$5 MillionStock Symbol
OPTIndustry
About Opthea
Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additionally, Opthea is exploring treatments for lymphangioleiomyomatosis (LAM), a rare disorder with significant unmet medical needs. Their target audience includes patients with retinal diseases and healthcare professionals involved in ophthalmology.Explore more
SIC Code 28,283NAICS Code 32,325Ticker ASX: OPTShow moreOpthea Org Chart
Compare Similar Companies to Opthea
Compare insights from companies similar to Opthea, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Opthea Tech Stack
A closer look at the technologies used by Opthea
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Opthea
Sign Up For FreeTo access detailed company insights
Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additiona... Read More